Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Subservient nurse stereotype is old fashioned.

Venables KM.

BMJ. 2018 Dec 4;363:k5086. doi: 10.1136/bmj.k5086. No abstract available.

PMID:
30514719
2.

Sarin Exposures in A Cohort of British Military Participants in Human Experimental Research at Porton Down 1945-1987.

Keegan TJ, Carpenter LM, Brooks C, Langdon T, Venables KM.

Ann Work Expo Health. 2017 Dec 15;62(1):17-27. doi: 10.1093/annweh/wxx084.

PMID:
29136135
3.

Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom.

Tsang Y, Ciurlionis L, Kirby AM, Locke I, Venables K, Yarnold JR, Titley J, Bliss J, Coles CE; IMPORT Trial Management Group.

Br J Radiol. 2015;88(1056):20150453. doi: 10.1259/bjr.20150453. Epub 2015 Oct 22.

4.

Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials.

Clark CH, Aird EG, Bolton S, Miles EA, Nisbet A, Snaith JA, Thomas RA, Venables K, Thwaites DI.

Br J Radiol. 2015;88(1055):20150251. doi: 10.1259/bjr.20150251. Epub 2015 Sep 2.

5.

A multi-institutional dosimetry audit of rotational intensity-modulated radiotherapy.

Clark CH, Hussein M, Tsang Y, Thomas R, Wilkinson D, Bass G, Snaith J, Gouldstone C, Bolton S, Nutbrown R, Venables K, Nisbet A.

Radiother Oncol. 2014 Nov;113(2):272-8. doi: 10.1016/j.radonc.2014.11.015. Epub 2014 Nov 23.

PMID:
25465734
6.

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, Dobbs HJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Simmons S, Sydenham MA, Venables K, Bliss JM, Yarnold JR; START Trialists' Group.

Lancet Oncol. 2013 Oct;14(11):1086-1094. doi: 10.1016/S1470-2045(13)70386-3. Epub 2013 Sep 19.

PMID:
24055415
7.

A UK pilot study: the specificity of the Word Memory Test effort sub-tests in acute minimal to mild head injury.

Hall VL, Worthington A, Venables K.

J Neuropsychol. 2014 Sep;8(2):216-30. doi: 10.1111/jnp.12021. Epub 2013 May 16.

PMID:
23679892
8.

Development of a novel treatment planning test for credentialing rotational intensity-modulated radiotherapy techniques in the UK.

Tsang Y, Ciurlionis L, Clark C, Venables K; NCRI Radiotherapy Trials Quality Assurance group.

Br J Radiol. 2013 Feb;86(1022):20120315. doi: 10.1259/bjr.20120315.

9.

Radiotherapy quality assurance: facilitation of radiotherapy research and implementation of technology.

Miles E, Venables K.

Clin Oncol (R Coll Radiol). 2012 Dec;24(10):710-2. doi: 10.1016/j.clon.2012.06.006. Epub 2012 Aug 1. No abstract available.

PMID:
22858426
10.

The impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapy.

Tsang Y, Haviland J, Venables K, Yarnold J; FAST Trial Management Group.

Radiother Oncol. 2012 Aug;104(2):143-7. Epub 2012 Jul 16.

PMID:
22809586
11.

Does participation in clinical trials influence the implementation of new techniques? A look at changing techniques in breast radiotherapy in the UK.

Venables K, Tsang Y, Ciurlionis L, Coles CE, Yarnold JR.

Clin Oncol (R Coll Radiol). 2012 Oct;24(8):e100-5. doi: 10.1016/j.clon.2012.06.010. Epub 2012 Jul 12.

PMID:
22795830
12.

Quality assurance analysis of participating centres' protocol compliance to a UK multicentre hypofractionated breast (FAST) trial.

Tsang Y, Venables K, Yarnold J; FAST Trial Management Group.

Br J Radiol. 2012 Sep;85(1017):e647-53. Epub 2012 Jan 31.

13.

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).

FAST Trialists group, Agrawal RK, Alhasso A, Barrett-Lee PJ, Bliss JM, Bliss P, Bloomfield D, Bowen J, Brunt AM, Donovan E, Emson M, Goodman A, Harnett A, Haviland JS, Kaggwa R, Morden JP, Robinson A, Simmons S, Stewart A, Sydenham MA, Syndikus I, Tremlett J, Tsang Y, Wheatley D, Venables K, Yarnold JR.

Radiother Oncol. 2011 Jul;100(1):93-100. doi: 10.1016/j.radonc.2011.06.026.

PMID:
21752481
14.

Cancer morbidity in British military veterans included in chemical warfare agent experiments at Porton Down: cohort study.

Carpenter LM, Linsell L, Brooks C, Keegan TJ, Langdon T, Doyle P, Maconochie NE, Fletcher T, Nieuwenhuijsen MJ, Beral V, Venables KM.

BMJ. 2009 Mar 24;338:b655. doi: 10.1136/bmj.b655.

15.

Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study.

Venables KM, Brooks C, Linsell L, Keegan TJ, Langdon T, Fletcher T, Nieuwenhuijsen MJ, Maconochie NE, Doyle P, Beral V, Carpenter LM.

BMJ. 2009 Mar 24;338:b613. doi: 10.1136/bmj.b613.

16.

Dosimetry and field matching for radiotherapy to the breast and supraclavicular fossa.

Miles EA, Venables K, Hoskin PJ, Aird EG; START Trial Management Group.

Radiother Oncol. 2009 Apr;91(1):42-8. doi: 10.1016/j.radonc.2008.11.016. Epub 2009 Feb 3.

PMID:
19195731
17.

Exposures recorded for participants in the UK Chemical Warfare Agent Human Research Programme, 1941-1989.

Keegan TJ, Walker SA, Brooks C, Langdon T, Linsell L, Maconochie NE, Doyle P, Fletcher T, Nieuwenhuijsen MJ, Carpenter LM, Venables KM.

Ann Occup Hyg. 2009 Jan;53(1):83-97. doi: 10.1093/annhyg/men040.

PMID:
19131404
18.

Quality of occupational health provision: two rating scales and their determinants.

Venables KM, Allender S.

Occup Med (Lond). 2008 Sep;58(6):439-42. doi: 10.1093/occmed/kqn076. Epub 2008 Jun 18.

PMID:
18562545
19.

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

START Trialists' Group, Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DA, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR.

Lancet Oncol. 2008 Apr;9(4):331-41. doi: 10.1016/S1470-2045(08)70077-9. Epub 2008 Mar 19.

20.

The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

START Trialists' Group, Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DA, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR.

Lancet. 2008 Mar 29;371(9618):1098-107. doi: 10.1016/S0140-6736(08)60348-7. Epub 2008 Mar 19.

21.

Reconstructing exposures from the UK chemical warfare agent human research programme.

Keegan T, Nieuwenhuijsen M, Fletcher T, Brooks C, Doyle P, Maconochie N, Carpenter L, Venables K.

Ann Occup Hyg. 2007 Jul;51(5):441-50. Epub 2007 Jun 30.

PMID:
17602209
22.

Occupational health provision in UK universities.

Venables KM, Allender S.

Occup Med (Lond). 2007 May;57(3):162-8. Epub 2007 Jan 16.

PMID:
17229719
23.

What determines the size of occupational health services in UK universities?

Venables KM, Allender S.

Occup Med (Lond). 2007 May;57(3):210-3. Epub 2007 Jan 16.

PMID:
17229718
24.

What is the optimum breast plan: a study based on the START trial plans.

Venables K, Miles EA, Aird EG, Hoskin PJ.

Br J Radiol. 2006 Sep;79(945):734-9.

PMID:
16940374
25.

Re: Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective.

Kunkler I, Russell N, Canney P, Venables K, Bartlett J.

J Natl Cancer Inst. 2006 Jul 19;98(14):1020-1; author reply 1021-2. No abstract available.

PMID:
16849687
26.

Symptoms, ill-health and quality of life in a support group of Porton Down veterans.

Allender S, Maconochie N, Keegan T, Brooks C, Fletcher T, Nieuwenhuijsen MJ, Doyle P, Carpenter LM, Venables KM.

Occup Med (Lond). 2006 Aug;56(5):329-37. Epub 2006 Jul 17.

PMID:
16847038
27.

Occupational health needs of universities: a review with an emphasis on the United Kingdom.

Venables KM, Allender S.

Occup Environ Med. 2006 Mar;63(3):159-67. Review.

28.

Verification films: a study of the daily and weekly reproducibility of breast patient set-up in the START trial.

Venables K, Miles EA, Hoskin PJ, Aird EG; START.

Clin Oncol (R Coll Radiol). 2005 Aug;17(5):337-42.

PMID:
16097564
29.

Preventive measures section 2: occupational allergies and asthma.

Venables K, Ring J, Sastre J.

Chem Immunol Allergy. 2004;84:152-62. Review. No abstract available.

PMID:
15496771
30.

World Allergy Organization guidelines for prevention of allergy and allergic asthma.

Asher I, Baena-Cagnani C, Boner A, Canonica GW, Chuchalin A, Custovic A, Dagli E, Haahtela T, Haus M, Lemmo-Hoten M, Holgate S, Holloway J, Holt P, Host A, Iikura Y, Johansson SG, Kaplan A, Kowalski ML, Lockey RF, Naspitz C, Odhiambo J, Ring J, Sastre J, Venables K, Vichyanond P, Volovitz B, Wahn U, Warner J, Weiss K, Zhong NS; World Allergy Organization.

Int Arch Allergy Immunol. 2004 Sep;135(1):83-92. No abstract available.

PMID:
15452918
31.

The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial.

Venables K, Miles EA, Aird EG, Hoskin PJ; START Trial Management Group.

Radiother Oncol. 2004 Jun;71(3):303-10.

PMID:
15172146
32.

Exposure-response relations for work related respiratory symptoms and sensitisation in a cohort exposed to alpha-amylase.

Brisman J, Nieuwenhuijsen MJ, Venables KM, Putcha V, Gordon S, Taylor AJ.

Occup Environ Med. 2004 Jun;61(6):551-3.

33.

Association of HLA-DQ5 and HLA-DR1 with sensitization to organic acid anhydrides.

Jones MG, Nielsen J, Welch J, Harris J, Welinder H, Bensryd I, Skerfving S, Welsh K, Venables KM, Taylor AN.

Clin Exp Allergy. 2004 May;34(5):812-6.

PMID:
15144476
34.

Irradiation of the heart during tangential breast treatment: a study within the START trial.

Venables K, Miles EA, Deighton A, Aird EG, Hoskin PJ.

Br J Radiol. 2004 Feb;77(914):137-42.

PMID:
15010386
35.

Survey of tangential field planning and dose distribution in the UK: background to the introduction of the quality assurance programme for the START trial in early breast cancer.

Winfield EA, Deighton A, Venables K, Hoskin PJ, Aird EG; START Trial Working Party.

Br J Radiol. 2003 Apr;76(904):254-9.

PMID:
12711645
36.

Exposure-response relations among laboratory animal workers exposed to rats.

Nieuwenhuijsen MJ, Putcha V, Gordon S, Heederik D, Venables KM, Cullinan P, Newman-Taylor AJ.

Occup Environ Med. 2003 Feb;60(2):104-8.

37.
38.

Interpretation of occupational peak flow records: level of agreement between expert clinicians and Oasys-2.

Baldwin DR, Gannon P, Bright P, Newton DT, Robertson A, Venables K, Graneek B, Barker RD, Cartier A, Malo JL, Wilsher M, Pantin CF, Burge PS.

Thorax. 2002 Oct;57(10):860-4.

39.
40.

Report on the potential allergenicity of genetically modified organisms and their products.

Lack G, Chapman M, Kalsheker N, King V, Robinson C, Venables K; BSACI working party.

Clin Exp Allergy. 2002 Aug;32(8):1131-43. No abstract available.

PMID:
12190648
41.

A survey of radiotherapy quality control practice in the United Kingdom for the START trial.

Venables K, Winfield E, Deighton A, Aird E, Hoskin P.

Radiother Oncol. 2001 Sep;60(3):311-8.

PMID:
11514011
42.

The START trial-measurements in semi-anatomical breast and chest wall phantoms.

Venables K, Winfield E, Deighton A, Aird E, Hoskin P; START Trial management group.

Phys Med Biol. 2001 Jul;46(7):1937-48.

PMID:
11474935
43.

Breast radiotherapy phantom design for the START trial. START trial management group.

Venables K, Winfield E, Deighton A, Aird E, Hoskin P; START Trial Management Group.

Br J Radiol. 2000 Dec;73(876):1313-6.

PMID:
11205676
44.

Allergen and dust exposure as determinants of work-related symptoms and sensitization in a cohort of flour-exposed workers; a case-control analysis.

Cullinan P, Cook A, Nieuwenhuijsen MJ, Sandiford C, Tee RD, Venables KM, McDonald JC, Newman Taylor AJ.

Ann Occup Hyg. 2001 Mar;45(2):97-103.

PMID:
11182423
45.

Risk factors for bronchial hyperresponsiveness in workers exposed to acid anhydrides.

Barker RD, van Tongeren MJ, Harris JM, Gardiner K, Venables KM, Newman Taylor AJ.

Eur Respir J. 2000 Apr;15(4):710-5.

46.

Exposure-response relations of alpha-amylase sensitisation in British bakeries and flour mills.

Nieuwenhuijsen MJ, Heederik D, Doekes G, Venables KM, Newman Taylor AJ.

Occup Environ Med. 1999 Mar;56(3):197-201.

47.

Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees.

Cullinan P, Cook A, Gordon S, Nieuwenhuijsen MJ, Tee RD, Venables KM, McDonald JC, Taylor AJ.

Eur Respir J. 1999 May;13(5):1139-43.

48.

Comparison of methods to assess airborne rat and mouse allergen levels. II. Factors influencing antigen detection.

Renström A, Gordon S, Hollander A, Spithoven J, Larsson PH, Venables KM, Heederik D, Malmberg P.

Allergy. 1999 Feb;54(2):150-7.

PMID:
10221438
49.

Comparison of methods to assess airborne rat and mouse allergen levels. I. Analysis of air samples.

Hollander A, Gordon S, Renström A, Thissen J, Doekes G, Larsson PH, Malmberg P, Venables KM, Heederik D.

Allergy. 1999 Feb;54(2):142-9.

PMID:
10221437
50.

Exposure-response relationships for work-related sensitization in workers exposed to rat urinary allergens: results from a pooled study.

Heederik D, Venables KM, Malmberg P, Hollander A, Karlsson AS, Renström A, Doekes G, Nieuwenhijsen M, Gordon S.

J Allergy Clin Immunol. 1999 Apr;103(4):678-84.

PMID:
10200019

Supplemental Content

Loading ...
Support Center